MedPath

Fenofibrate

These highlights do not include all the information needed to use FENOFIBRATE TABLETS safely and effectively. See full prescribing information for FENOFIBRATE TABLETS FENOFIBRATE tablets for oral use Initial U.S. Approval: 1993

Approved
Approval ID

41f0f514-1fa9-47a0-a085-a31354842f96

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 1, 2022

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fenofibrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71205-949
Application NumberANDA207803
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fenofibrate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 1, 2022
FDA Product Classification

INGREDIENTS (1)

FENOFIBRATEActive
Quantity: 160 mg in 1 1
Code: U202363UOS
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fenofibrate - FDA Drug Approval Details